- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANO HEALTH Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 399,25 | -0,99 % | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | ||
| UNITEDHEALTH | 361,80 | -0,33 % | UnitedHealth (UNH) BMO CDR (CAD Hedged): UnitedHealth (UNH) BMO CDR estimates distribution | ||
| THERMO FISHER | 643,00 | -0,12 % | Thermo Fisher Scientific (TMO) Is Benefiting From More Than Healthcare Demand: Here's the Overlooked AI Connection | ||
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CENTENE | 61,42 | -2,35 % | Nach der US-Wahl: Diese Aktien werden jetzt zu Gewinnern - deutsche Konzerne dabei | © Foto: wO-GeminiDer Wahlsieg der Demokraten verändert die Spielregeln an der Börse. Solaraktien schießen nach oben, auch Europas Industrie hofft auf Entlastung. Welche Unternehmen kurz- und langfristig... ► Artikel lesen | |
| QUIDELORTHO | 10,730 | +3,82 % | QuidelOrtho expects over $80M in 2027 annual savings as it narrows 2026 revenue to $2.52B-$2.54B | ||
| VERU | 2,140 | +0,94 % | Veru executive to present obesity drug data at industry conference | ||
| TEMPEST THERAPEUTICS | 0,373 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| NANO-X IMAGING | 0,378 | +1,18 % | Nanox.AI signs distribution deal for cardiac imaging in Thailand | ||
| FULGENT GENETICS | 23,400 | +0,86 % | Fulgent forecasts 2026 revenue of $330M-$340M while narrowing non-GAAP loss to (-$1.65)-(-$1.75) per share | ||
| PERSPECTIVE THERAPEUTICS | 0,810 | +14,66 % | Perspective Therapeutics Analysts Slash Their Forecasts After Q3 Results | ||
| LANTHEUS | 91,10 | 0,00 % | PharmaLogic Holdings Corp: PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility | Expands U.S. therapeutic manufacturing capacity and creates the first transatlantic CDMO platform with a proven commercial track record in radioligand therapies WALTHAM, Mass., Nov. 9, 2026 /PRNewswire/... ► Artikel lesen | |
| OMNICELL | 32,800 | +1,86 % | OMNICELL, INC. - 10-Q, Quarterly Report | ||
| AMN HEALTHCARE SERVICES | 33,400 | +1,21 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Third Quarter 2026 Results | Quarterly revenue of $717 million and adjusted EBITDA of $94 million; GAAP net income of $0.83/share and adjusted EPS of $1.16 DALLAS, Nov. 5, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE:... ► Artikel lesen |
CANO HEALTH INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANO HEALTH INC finden Sie auf Wallstreet Online.